In a neutrophil-dependent arthritis elicited by injections of a mixture of anti -type II collagen mAbs followed by LPS, mice lacking the tyrosine-based inhibitory receptor leukocyte Iglike receptor B4 (LILRB4) have an exacerbated clinical response characterized morphologically by greater synovial thickening with neutrophil infi ltration and depletion of articular cartilage matrix with erosions, compared with Lilrb4 + mice ( 1 ). LILRB4 is expressed on and regulates pathobiologic functions of neutrophils in a vasculopathy model ( 2 ) and mast cells in anaphylaxis ( 3 ). Neutrophil infi ltration in the arthritis model was greater in the aff ected joints of LILRB4 null ( Lilrb4 − ) mice compared with Lilrb4 + mice, whereas the number and degranulation of synovial mast cells was not diff erent in the two strains. However, the fi nding that Lilrb4 − mice generate greater amounts of IL-1 ␤ , macrophage infl ammatory protein 1 ␣ , and macrophage infl ammatory protein 2 in the infl amed joints ( 1 ), each of which contributes to the tissue injury in this model, raises the possibility that mast cells might participate in a manner not revealed by numbers or degranulation, particularly because mast cells provide IL-1 ␤ during the initiating phase of infl ammatory arthritis induced by injection of antibodies (Abs) to glucose 6-phosphate isomerase (GPI) ( 4 ). In the latter model, mast cell -defi cient Kit W /Kit W-v mice do not develop arthritis but are rendered susceptible by adoptive transfer of BM-derived mast cells from IL-1 ␤ + mice, but not from IL-1 ␤ − mice.
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We report here the unexpected fi nding that Kit W- ( Fig. 1 B ) .
Histologic and functional evidence of mast cell defi ciency in Kit W-sh mice We confi rmed that our Kit W-sh mice were mast cell defi cient by histologic and functional criteria at the age range at which arthritis was induced. As determined in tissue sections stained for chloroacetate esterase (CAE) activity, there were essentially no mast cells in the synovium and subsynovium of the ankle joint, tongue, spleen, liver, kidney, heart, or intestine of 5 -9-wk-old naive Kit W-sh mice, and the number of mast cells in the ear skin and the dermis adjacent to the subsynovium of the ankle joint was 1.7 and 3.4%, respectively, of the number in Kit + mice ( n = 4 -7). Estimates of the number of mast cells in the ear and back skin of 10-wk-old Kit W-sh mice have ranged from 6 -10% of that of Kit + mice, as assessed by alcian blue ( 6 ) or toluidine blue staining ( 7 ) of tissue sections, to not detectable in the ear skin by methylene blue staining or CAE activity ( 8 ) . Kit + but not Kit W-sh mice exhibited passive cutaneous anaphylaxis (PCA) reactions in the ear and paw as measured by extravasation of Evans Blue dye-bearing protein ( Fig. 2 ) ( Fig. 1 A ) . Furthermore, there were no signifi cant diff erences in Kit + and Kit W-sh mice at day 7 in synovial thickness, cartilage matrix depletion, and synovial neutrophilia in ankle joints as assessed histologically (55 ± 5.4 vs. 52.7 ± 6.1 μ m, 22.6 ± 2.2 vs. 17.0 ± 2.8% depletion, and 19.0 ± 6.1 vs. 21.2 ± 7.4 neutrophils/unit area; P = 0.8, 0.1, and 0.8, respectively; n = 9). Induction of less joint swelling by reducing the anti-collagen dose to 0.5 mg resulted in peak clinical scores on day 7 in Kit + and Kit W-sh mice of 2.3 ± 0.9 and 2.7 ± 0.9 ( n = 3; P = 0.8), respectively, indicating that no eff ect of mast cell defi ciency was uncovered even at the lower limit of clinical detection. Because we had expected a mast cell Mice were injected i.d. in one ear or s.c. in one paw with 25 and 75 ng of mouse monoclonal IgE anti-DNP, respectively, and were injected in the other ear or paw with saline. After 20 h, the mice were injected i.v. with 100 g DNP-HSA/1% Evans blue. After 0.5 h, mice were killed, their ears and paws were excised, and the Evans blue was extracted with formamide and quantifi ed by spectrophotometry. Data are expressed as mean ± SEM; n = 7 -9 from two experiments (ear) and n = 5 from three experiments (paw).
signifi cantly lower 31% of that of WBB6F1-Kit + mice, and reached ‫ف‬ 80% of normal at 6 mo. The number of BM neutrophils in Kit W /Kit W-v mice was a signifi cantly lower 52 -64% of that of WBB6F1-Kit + mice from 3 to 6 mo of age. Even in older Kit W /Kit W-v mice with near normal peripheral blood neutrophil levels, the increase in neutrophils 6 h after i.p. injection of 5 μ g LPS was only ‫ف‬ 60% of that of WBB6F1-Kit + mice ( 13 ) . Naive Kitl Sl / Kitl Sl-d mice that are on the WCB6F1 background and are stem cell factor defi cient ( 14 ) also have a BM and peripheral blood neutropenia ( 15 ) .
In contrast with Kit W /Kit W-v mice, the concentration of neutrophils in the blood of naive 7 -9-wk-old Kit W-sh mice was not diff erent than that of Kit + controls ( Fig. 3 ) . Injection of 25 μ g LPS i.p. induced comparable increases in the concentration of peripheral blood neutrophils after 24 h in Kit + and Kit W-sh mice, respectively ( Fig. 3 ) . 24 h after i.d. injection of 50 μ g LPS, there was no signifi cant diff erence in the number of neutrophils in the blood of Kit + and Kit W-sh mice (2.0 ± 0.21 vs. 1.9 ± 0.21 × 10 3 cells per μ l, respectively; n = 3 -4) or migration of neutrophils into the ears (13.9 ± 1.2 vs. 12.2 ± 3.5 neutrophils per unit length, respectively; n = 6 -8; P = 0.7 ( 7, 19 ) , whereas both strains have defi ciencies in melanocytes ( 20 ) and interstitial cells of Cajal ( 7 ) . Because the absence of mast cells in Kit W-sh mice resulted from a 2-cM inversion upstream of the Kit gene in C3H/HeJ × 101/H F1 mice ( 19, 21 ) , it is possible that the retention of certain alleles from the F1 strain even after backcrossing into C57BL6 mice contributes to the phenotypic diff erences of Kit W-sh mice compared with Kit W /Kit W-v mice.
Splenic, but not BM, myeloid hyperplasia in Kit W-sh mice As part of a general histologic assessment for tissue mast cells, we noted that the spleens of Kit W-sh mice as compared with their Kit + controls had a signifi cant 2.4-fold greater number of CAE + cells with myeloid morphology ( Fig. 4 A ) that had a primarily subcapsular localization and included a signifi cantly greater percentage of immature forms (68 ± 7% and 16 ± 4%, respectively; n = 3; P = 0.004). Induction of synovitis with anti-collagen/LPS caused an increase in the splenic CAE + cells in both strains that reached a signifi cantly greater level in the Kit W-sh mice ( Fig. 4 A ) cells per μ l, respectively; n = 9 -11; P = 0.0002) and recruited into the ears (5.8 ± 0.8 vs. 13.3 ± 1.7 neutrophils per unit length, respectively; n = 11 -12; P = 0.008). Our data confi rm and extend the fi ndings of Chervenick and Boggs reported in 1969 ( 13 ) , which indicated that the concentration of peripheral blood neutrophils in naive 3-moold Kit W /Kit W-v mice (the youngest mice examined) was a than in Lilrb4 + / Kit W-sh mice (P = 0.03; Fig. 5 ). Histologic analysis of the synovial thickness in the talo-tibial articulation of the ankle joint at day 7 revealed a trend toward greater thickness in Lilrb4 − / Kit W-sh mice compared with Lilrb4 + / Kit W-sh mice (71.0 ± 10 vs. 52.7 ± 6.1 μ m, respectively; n = 9; P = 0.1; the measurements were made in the same experiments that provided the comparison of Kit + and Kit W-sh mice noted above). Moreover, as assessed by digital image analysis of the loss of staining with safranin O, there was a signifi cant approximately twofold greater depletion of cartilage matrix at day 7 in Lilrb4 − / Kit W-sh mice compared with Lilrb4 + / Kit W-sh mice (32.2 ± 6.3 vs. 17.0 ± 2.8%; n = 9; P = 0.04). Hence, the exacerbation of these characteristics in the absence of LILRB4 proceeds without a mast cell infl uence, compatible with a central role for neutrophils.
To establish an absolute neutrophil requirement in the LILRB4-suffi cient and -defi cient Kit W-sh strains, mice were injected i.p. with anti -Gr-1 on days 2 and 4 of the anti-collagen/ LPS protocol, as done previously with Lilrb4 + and Lilrb4 − mast cell -suffi cient mice on the BALB/c background ( 1 ). Treatment with anti -Gr-1 depleted peripheral blood neutrophils by > 95% compared with untreated mice and suppressed clinical scores in both Lilrb4 + / Kit W-sh (0 ± 0 vs. 6.0 ± 3, respectively) and Lilrb4 − / Kit W-sh mice (0 ± 0 vs. 9.0 ± 0) at day 7 ( n = 2 -5 mice per genotype).
In addressing the discrepancy as to why the Kit W-sh but not Kit W /Kit W-v mast cell -defi cient strain is fully susceptible to anti-collagen/LPS-induced arthritis, we confi rmed an old observation that Kit W /Kit W-v mice are neutropenic and mobilize blood neutrophils poorly ( 13 ) . Although there are also defi ciencies in other lineages in Kit W /Kit W-v mice that are not present in Kit W-sh mice, we have focused on the neutrophil because of its prominence in the model. This has recently been highlighted in studies of arthritis induced with Ab to GPI in which clinical and tissue pathology was interrupted when the number of neutrophils fell due to blockade of their continuous recruitment from blood by local generation or action of leukotriene B 4 with inhibitors of 5-lipoxygenase or dispersed splenocytes from naive Kit + and Kit W-sh mice were 7 ± 2 and 32 ± 7% Gr-1 + , respectively ( n = 4; P = 0.01; representative histograms are presented in Fig. 4 B ) , consistent with the greater number of CAE + myeloid cells in Kit W-sh mice. In contrast, there was no diff erence in the number of CAE + cells in the BM of Kit + and Kit W-sh mice (64 ± 6.5 and 70 ± 1.2 cells per high power fi eld, respectively; n = 4). There was also no diff erence in the number of BM cells recovered from the femurs and tibias of Kit + and Kit W-sh mice (5.4 ± 1.5 and 5.8 ± 1.4 × 10 7 , cells/mouse, respectively; n = 3) or in the percentage of Gr-1 + cells in the BM (72 ± 8 and 77 ± 5%, respectively; n = 3 -4). Because the BM of Kit W-sh mice lacked these changes, and the blood level and recruitment of neutrophils in the joints and ears of Kit W-sh mice was the same as in Kit + mice with no increase in morphologically immature myeloid cells, there was no evidence that the splenic dysmyelopoiesis was a factor in the normal response to anticollagen/LPS-induced arthritis in mast cell -defi cient Kit W-sh mice. Indeed, there was no diff erence in Kit + and Kit W-sh mice at day 7 of the anti-collagen mAbs/LPS model in the number of peripheral blood neutrophils (1.9 ± 0.7 and 1.5 ± 0.5 × 10 3 / μ l, respectively; n = 4; P = 0.6) and neutrophils per unit area in the synovium (19.6 ± 6.8 and 21.2 ± 7.4 cells/unit area, respectively; n = 9; P = 0.8) and joint space (5.8 ± 1 and 8.4 ± 2.6 cells/unit area, respectively; n = 9; P = 0.3) at day 7. Mice were injected and their clinical scores were determined as described in the legend for Fig. 1 , except that 1 mg of anti-collagen was used. Data are expressed as mean ± SEM; n = 9 from three experiments.
local edema; 2, swelling localized to either the dorsal or ventral surface of a paw; 3, swelling on all aspects of a paw ( 1 ) . The sum of the four scores was defi ned as the clinical score for each mouse. Synovial thickness was measured in histologic sections of the talo-tibial articulation of the ankle joint stained for CAE activity as described previously ( 1 ) . Cartilage matrix depletion was measured in sections stained with Safranin O as described previously ( 1 ), except that the areas of cartilage matrix depletion within the cartilaginous regions were outlined in digital photomicrographs, converted to pixels with ImageJ software (Image Processing and Analysis in Java developed by the National Institutes of Health), and expressed as a percentage of the total cartilaginous region. Quantifi cation of LPS-induced neutrophilia was performed in ear sections stained for CAE activity ( 2 ).
IgE-dependent anaphylaxis. For PCA in the ear, mice were injected i.d. in one ear with 25 ng IgE anti-DNP (SPE-7; Sigma-Aldrich) and with an equal volume of saline (20 μ l) in the other ear. 20 h later, mice were injected i.v. with 100 g DNP-HSA (30 -40 moles DNP/HSA; Sigma-Aldrich) in 100 l of 1% Evans Blue dye. After 0.5 h, mice were killed, ear tissue was obtained with a 6-mm diameter punch, dye was extracted from the tissue by incubation in 200 l of formamide at 58 ° C for 48 h, the tissue was pelleted by centrifugation, and the dye in the supernatant was quantifi ed spectrophotometrically ( 3, 29 ) . For PCA in the paw, mice were injected s.c. in one hind paw with 75 ng IgE anti-DNP and in the other hind paw with an equal volume (10 μ l) of saline. Mice were challenged with antigen and Evans blue, killed, and the paws were collected from the fur line and cut into small pieces. The dye was extracted as for PCA in the ear except that an extraction volume of 1 ml was used. For IgE-dependent systemic anaphylaxis, mice were injected i.v. with 40 μ g of rat anti -mouse IgE (R35-72; BD Biosciences).
Peripheral blood neutrophil counts and Ab-mediated depletion.
Blood was collected, and leukocyte counts and diff erentials were determined with an automated cell counter as described previously ( 1 ) . For neutrophil depletion, mice were injected i.p. with rat anti -Gr-1 mAb or rat IgG2b isotype control mAb ( 1, 12 ) . the BLT 1 receptor ( 22, 23 ) . The fi nding that a critical concentration of neutrophils must be achieved to control the growth of bacteria in tissue ( 24 ) may be relevant to the requirement for presence of a suffi cient concentration of neutrophils to induce infl ammation and tissue pathology in the arthritis models. That the absence of the control receptor LILRB4 in mast cell -defi cient Kit W-sh mice augments the clinical and tissue pathology in the anti-collagen/LPS model again supports the importance of neutrophils as opposed to mast cells, but does not exclude a contribution by other cell types lacking the receptor. Our fi ndings do not question a role for adoptively transferred WT BM-derived mast cells in uncovering the arthritic potential of mAb in the Kit W /Kit W-v strain as shown in the anti-GPI model ( 5 ), but rather suggest that the limitation of other cell types, such as neutrophils, allows recognition of a mast cell contribution. Indeed, engraftment of mast cells into Kit W /Kit W-v mice corrects a defi ciency in the infl ux of peritoneal neutrophils in response to i.p. injection of peptidoglycan ( 25 ) . Naive WBB6F1-Kit + mice have six times the number of peritoneal mast cells as C57BL/6-Kit + mice, and 24 h after cecal ligation and puncture have 20 times the number of peritoneal neutrophils ( 26 ) . The propensity for elevated numbers of mast cells and neutrophils in WBB6F1-Kit + mice combined with the neutropenia in mast cell -defi cient Kit W /Kit W-v mice may magnify the contribution of mast cells to neutrophil-dependent models of infl ammation in this strain compared with the C57BL/6 strain. Hence, our fi ndings suggest that a potential role for mast cells is not always critical, and that the availability of a second mast cell -defi cient strain allows separation of absolute and relative roles for mast cells in disease models.
MATERIALS AND METHODS
Mice. Lilrb4 +/ − mice on a mixed 129/BALB/c background ( 3 ) were backcrossed to B6 mice fi ve times, and for the last four of those backcrosses, mice with the greatest number of B6 alleles were selected by microsatellite analyses (Charles River Laboratories). The resulting backcrossed Lilrb4 +/ − mice were intercrossed, and their homozygous progeny were bred in parallel to yield Lilrb4 + and Lilrb4 − mice. Kit W-sh mice, backcrossed at least 10 times to the B6 background, were obtained via D. Lee (Brigham and Women ' s Hospital, Boston, MA) from P. Wolters and G. Caughey (University of California, San Francisco, San Francisco, CA) ( 27 ) , who obtained them from P. Besmer (Memorial Sloan-Kettering Cancer Center, New York, NY). The mice were bred with Lilrb4 − mice to yield Lilrb4 +/ − /Kit +/W-sh mice, which were intercrossed to produce Lilrb4 + / Kit W-sh and Lilrb4 − / Kit W-sh mice. 7 -9-wk-old male mice were used for experiments. Mice were maintained in a specifi c pathogenfree barrier facility at the Dana-Farber Cancer Institute, and the studies were approved by the Animal Care and Use Committee.
Induction of proliferative synovitis. Mice were injected i.v. with a mixture of anti -type II collagen mAbs (Chemicon International Inc.), followed 3 d later by an i.p. injection of LPS ( Escherichia coli O111:B4; Chemicon) ( 1, 28 ) at the doses indicated in the Results. Because the intensity of clinical pathology obtained with diff erent batches of anti-collagen varied, doses were chosen that provided an average peak clinical score (described below) of at least 5.
Clinical and histologic analyses.
A clinical score for joint swelling in each leg was assigned according to the following scale: 0, no detectable swelling; 1, swelling in metatarsal phalange joints, an individual phalanx, or
